Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAIL, Bim, and thymic-negative selection.

Shi-Jun Zheng1, Youhai H Chen

  • 1Department of Pathology and Laboratory Medicine, School of Medicine, University of Pennsylvania, Philadelphia, PA.

Immunologic Research
|January 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Administration of neuritin as a novel therapeutic strategy for autoimmune and inflammatory diseases.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

TIPE2 gene knockdown in mice attenuates experimental colitis by diminishing inflammatory cell infiltration.

Molecular therapy. Nucleic acids·2026
Same author

Tumor cell AMPK activation enhances NK cell anti-tumor immunity and synergizes with PD-L1 blockade therapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

DR5 CAR-NK cells demonstrate superior scalability and potent antitumor activity with favorable safety.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Cancer immunotherapy by silencing transcription factor c-Rel using peptide-based nanoparticles.

Frontiers in immunology·2025
Same author

Akt2 deficiency impairs Th17 differentiation, augments Th2 differentiation, and alters the peripheral response to immunization.

bioRxiv : the preprint server for biology·2024

Negative selection eliminates self-reactive lymphocytes, crucial for preventing autoimmune diseases. This review highlights the roles of TRAIL and Bim in T cell negative selection, clarifying molecular mechanisms.

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmunity

Background:

  • Negative selection, the deletion of autoreactive lymphocytes via apoptosis, is vital for maintaining self-tolerance.
  • Breakdown of negative selection mechanisms is implicated in the pathogenesis of autoimmune diseases.
  • The precise molecular underpinnings of negative selection remain incompletely understood.

Purpose of the Study:

  • To review recent insights into the molecular mechanisms of negative selection.
  • To discuss the newly identified roles of TRAIL and Bim in lymphocyte deletion.
  • To focus on T cell negative selection and its relevance to T cell-mediated autoimmune diseases.

Main Methods:

  • Review of recent scientific literature.
  • Analysis of findings from gene-knockout mouse studies.

Related Experiment Videos

  • Focus on molecular pathways involved in lymphocyte apoptosis.

    • Main Results:

    • Recent studies have elucidated novel roles for TRAIL (TNF-related apoptosis-inducing ligand) in negative selection.
    • Bim, a pro-apoptotic protein, has been identified as a key mediator in lymphocyte deletion processes.
    • These findings provide new molecular targets for understanding and potentially treating autoimmune conditions.

    Conclusions:

    • TRAIL and Bim are critical molecular players in the process of negative selection.
    • Understanding these mechanisms offers new avenues for therapeutic intervention in autoimmune diseases.
    • Further research into these pathways is essential for advancing self-tolerance strategies.